ERAS

Erasca (ERAS)

About Erasca (ERAS)

Erasca, Inc. is a clinical stage precision oncology company. It focuses on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. It has assembled a wholly owned or controlled RAS/MAPK pathway focused pipeline comprising modality-agnostic programs. The company was founded by Jonathan E. Lim and Kevan Shokat on July 2, 2018 and is headquartered in San Diego, CA.

Details

Daily high

$13.32

Daily low

$12.41

Price at open

$12.53

52 Week High

$24.28

52 Week Low

$1.21

Market cap

3.7B

Dividend yield

0.00%

Volume

5.9M

Avg. volume

4.9M

P/E ratio

-12.83

Erasca News